AI Backers Fund a $500M Push to End Colds
Stripe, Anthropic, the OpenAI Foundation, and other donors formed Intercept, a $500 million nonprofit focused on preventing respiratory viruses and improving indoor air. The effort will fund shots, sprays, pills, and cleaner-air technology for offices and schools. Its goal is to move early research far enough that pharma firms and investors can take over the expensive final stretch.
- Intercept is targeting two product categories: broad-spectrum preventatives and air-cleaning technologies that can work together rather than relying on a single intervention.
- The group wants preventatives that can block more than 75% of symptomatic respiratory infections with easy administration and a credible path to broad adoption.
- For air cleaning, the target is to safely cut infectious aerosols by more than 75% in transmission-relevant indoor spaces at low cost.
